Open access
Outcomes of ibrutinib plus lenalidomide combination in patients with large Bcell lymphoma refractory to or relapsing after CAR-T-cell therapy and who failed or were ineligible for bispecific antibodies: a multicenter real-world REALI-T study.
Carl J. Rudebeck
L. Fornecker
B. Guffroy
L. Fouillet
A. Chauchet
A. Caillet
F. Gros
G. Brisou
H. Manjra
V. Camus
S. Guidez
Fabien Claves
D. Beauvais
Maryam Idlhaj
C. Golfier
V. Safar
E. Ferrant
Emmanuel Bachy
H. Ghesquières
P. Sesques
Medicine
Abstract
Not available.